Model
Edge
EyePoint Pharmaceuticals Inc.
0001736240
Filing Type
4/A
Filing Date
9/5/2023
Updated
9/6/23, 1:10 PM
Filing
4/A
Earnings Release
Exhibits
4/A
Amended Statement of Changes in Beneficial Ownership